Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

CDC Science Clips

Drug Safety

  1. Antiretroviral drug use during pregnancy and risk of premature delivery: is there a connection?
    Kourtis AP.
    J Infect Dis. 2010 Apr 1;201(7):978-80.

  2. Therapeutic errors among children in the community setting: nature, causes and outcomes
    Mc DT, Robinson J, MacLeod D, MacBean CE, Braitberg G.
    J Paediatr Child Health. 2009 May;45(5):304-9.

  3. Severe injury or death in young children from therapeutic errors: a summary of 238 cases from the American Association of Poison Control Centers
    Tzimenatos L, Bond GR.
    Clin Toxicol (Phila). 2009 Apr;47(4):348-54.

  4. Parents' medication administration errors: role of dosing instruments and health literacy
    Yin HS, Mendelsohn AL, Wolf MS, Parker RM, Fierman A, van Schaick L, Bazan IS, et al.
    Arch Pediatr Adolesc Med. 2010 Feb;164(2):181-6.

  5. Pediatric adverse drug events in the outpatient setting: an 11-year national analysis
    Bourgeois FT, Mandl KD, Valim C, Shannon MW.
    Pediatrics. 2009 Oct;124(4):e744-50.

  6. The role of advice in medication administration errors in the pediatric ambulatory setting
    Lemer C, Bates DW, Yoon C, Keohane C, Fitzmaurice G, Kaushal R.
    J Patient Saf. 2009 Sep;5(3):168-75.

  7. Impact of poor-quality medicines in the 'developing' world
    Newton PN, Green MD, Fernandez FM.
    Trends Pharmacol Sci. 2010 Mar;31(3):99-101.

  8. Medicare part D's exclusion of benzodiazepines and fracture risk in nursing homes
    Briesacher BA, Soumerai SB, Field TS, Fouayzi H, Gurwitz JH.
    Arch Intern Med. 2010 Apr 26;170(8):693-8.

  9. Hemorrhage during warfarin therapy associated with cotrimoxazole and other urinary tract anti-infective agents: a population-based study
    Fischer HD, Juurlink DN, Mamdani MM, Kopp A, Laupacis A.
    Arch Intern Med. 2010 Apr 12;170(7):617-21.

  10. Association of community-acquired pneumonia with antipsychotic drug use in elderly patients: a nested case-control study
    Trifiro G, Gambassi G, Sen EF, Caputi AP, Bagnardi V, Brea J, Sturkenboom MC.
    Ann Intern Med. 2010 Apr 6;152(7):418-25, W139-40.

  11. Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur
    Black DM, Kelly MP, Genant HK, Palermo L, Eastell R, Bucci-Rechtweg C, Cauley J, et al.
    N Engl J Med. 2010 May 13;362(19):1761-71.

  12. Influenza vaccination and vitamin K antagonist treatment: a placebo-controlled, randomized, double-blind crossover study
    Iorio A, Basileo M, Marcucci M, Guercini F, Camilloni B, Paccamiccio E, Vecchioli M, et al.
    Arch Intern Med. 2010 Apr 12;170(7):609-16.

  13. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial
    Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D, Nicholson GC.
    JAMA. 2010 May 12;303(18):1815-22.

  14. Hormone therapy and fatal breast cancer
    Norman SA, Weber AL, Localio AR, Marchbanks PA, Ursin G, Strom BL, Weiss LK, Burkman RT, Bernstein L, Deapen DM, Folger SG, Simon MS, Nadel MR.
    Pharmacoepidemiol Drug Saf. 2010 May;19(5):440-7.

  15. Death due to community-associated Clostridium difficile in a woman receiving prolonged antibiotic therapy for suspected Lyme Disease
    Holzbauer SM, Kemperman MM, Lynfield R.
    Clin Infect Dis. 2010 Aug 1;51(3):369-70.

  16. Maternal use of bupropion and risk for congenital heart defects
    Alwan S, Reefhuis J, Botto LD, Rasmussen SA, Correa A, Friedman JM.
    Am J Obstet Gynecol. 2010 Jul;203(1):52 e1-6.

  17. Effect of glucosamine on pain-related disability in patients with chronic low back pain and degenerative lumbar osteoarthritis: a randomized controlled trial
    Wilkens P, Scheel IB, Grundnes O, Hellum C, Storheim K.
    JAMA. 2010 Jul 7;304(1):45-52.

  18. Safety of contraceptive use among women with peripartum cardiomyopathy: a systematic review
    Tepper NK, Paulen ME, Marchbanks PA, Curtis KM.
    Contraception. 2010 Jul;82(1):95-101.

  19. Contraceptive use among women with inflammatory bowel disease: A systematic review
    Zapata LB, Paulen ME, Cansino C, Marchbanks PA, Curtis KM.
    Contraception. 2010 Jul;82(1):72-85.

  20. Management of prescription and nonprescription drug use during pregnancy
    Morgan MA, Cragan JD, Goldenberg RL, Rasmussen SA, Schulkin J.
    J Matern Fetal Neonatal Med. 2010 Aug;23(8):813-9.

  21. The Ribavirin Pregnancy Registry: findings after 5 years of enrollment, 2003-2009
    Roberts SS, Miller RK, Jones JK, Lindsay KL, Greene MF, Maddrey WC, Williams IT, Liu J, Spiegel RJ.
    Birth Defects Res A Clin Mol Teratol. 2010 Jul;88(7):551-9.

  22. Increased risk of stroke associated with nonsteroidal anti-inflammatory drugs. A nationwide case-crossover study
    Chang CH, Shau WY, Kuo CW, Chen ST, Lai MS.
    Stroke. 2010 Jul 29.

  23. Antipsychotic and benzodiazepine use among nursing home residents: findings from the 2004 National Nursing Home Survey
    Stevenson DG, Decker SL, Dwyer LL, Huskamp HA, Grabowski DC, Metzger ED, Mitchell SL.
    Am J Geriatr Psychiatry. 2010 Jun 22.

  24. Effects of statins on serum inflammatory markers: the U.S. National Health and Nutrition Examination Survey 1999-2004
    Yoon SS, Dillon CF, Carroll M, Illoh K, Ostchega Y.
    J Atheroscler Thromb. 2010 Aug 25.

  25. Henoch-Scholein purpura and polysaccharide meningococcal vaccine
    Goodman MJ, Nordin JD, Belongia EA, Mullooly JP, Baggs J.
    Pediatrics. 2010 Aug;126(2):e325-9.

  26. Levamisole: a dangerous new cocaine adulterant
    Chang A, Osterloh J, Thomas J.
    Clin Pharmacol Ther. 2010 Sep;88(3):408-11.

  27. Utah clinical guidelines on prescribing opioids for treatment of pain
    Rolfs RT, Johnson E, Williams NJ, Sundwall DN.
    J Pain Palliat Care Pharmacother. 2010 Sep;24(3):219-35.

  28. Increase in unintentional medication overdose deaths Oklahoma, 1994-2006
    Piercefield E, Archer P, Kemp P, Mallonee S.
    Am J Prev Med. 2010 Oct;39(4):357-63.

  29. Prescription drug use continues to increase: U.S. prescription drug data for 2007-2008
    Gu Q, Dillon CF, Burt VL.
    NCHS Data Brief. 2010 Sep(42):1-8.

  30. Obstetrician-gynaecologist knowledge of and access to information about the risks of medication use during pregnancy
    Morgan MA, Cragan JD, Goldenberg RL, Rasmussen SA, Schulkin J.
    J Matern Fetal Neonatal Med. 2010 Oct;23(10):1143-50.

  31. Diethylene glycol in health products sold over-the-counter and imported from Asian countries
    Schier JG, Barr DB, Li Z, Wolkin AF, Baker SE, Lewis LS, McGeehin MA.
    J Med Toxicol. 2010 Oct 7.

  32. FDA on rosiglitazone: more on advisory committee decision
    Graham DJ, Gelperin K.
    BMJ. 2010 Sep 11;341:c4868.

  33. Improving drug safety surveillance: lessons from rosiglitazone
    Masoudi FA.
    Circ Cardiovasc Qual Outcomes. 2010 Sep 1;3(5):444-6.

  34. Impact of thiazolidinedione safety warnings on medication use patterns and glycemic control among veterans with diabetes mellitus
    Shi L, Zhao Y, Szymanski K, Yau L, Fonseca V.
    J Diabetes Complications. 2010 Aug 11.

  35. Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone
    Graham DJ, Ouellet-Hellstrom R, MaCurdy TE, Ali F, Sholley C, Worrall C, Kelman JA.
    JAMA. 2010 Jul 28;304(4):411-8.

  36. Balancing hypoglycemia and glycemic control: a public health approach for insulin safety
    Pogach L, Aron D.
    JAMA. 2010 May 26;303(20):2076-7.

  37. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial
    Ismail-Beigi F, Craven T, Banerji MA, Basile J, Calles J, Cohen RM, Cuddihy R, et al.
    Lancet. 2010 Aug 7;376(9739):419-30.

  38. Severe hypoglycemia and risks of vascular events and death
    Zoungas S, Patel A, Chalmers J, de Galan BE, Li Q, Billot L, Woodward M, et al.
    N Engl J Med. 2010 Oct 7;363(15):1410-8.

  39. Use of clomiphene citrate and birth defects, National Birth Defects Prevention Study, 1997-2005
    Reefhuis J, Honein MA, Schieve LA, Rasmussen SA.
    Hum Reprod. 2010 Nov 26.

  40. National estimates of emergency department visits for hemorrhage-related adverse events from clopidogrel plus aspirin and from warfarin
    Shehab N, Sperling LS, Kegler SR, Budnitz DS.
    Arch Intern Med. 2010 Nov 22;170(21):1926-33.

  41. 20 microg versus >20 microg estrogen combined oral contraceptives for contraception
    Gallo MF, Nanda K, Grimes DA, Lopez LM, Schulz KF.
    Cochrane Database Syst Rev. 2011 ;1:CD003989.

  42. An analysis of heavy utilizers of opioids for chronic noncancer pain in the TROUP study
    Edlund MJ, Martin BC, Fan MY, Braden JB, Devries A, Sullivan MD.
    J Pain Symptom Manage. 2010 Aug;40(2):279-89.

  43. Usefulness of prescription monitoring programs for surveillance--analysis of Schedule II opioid prescription data in Massachusetts, 1996-2006
    Katz N, Panas L, Kim M, Audet AD, Bilansky A, Eadie J, Kreiner P, et al.
    Pharmacoepidemiol Drug Saf. 2010 Feb;19(2):115-23.

  44. Adverse antiepileptic drug effects in new-onset seizures: a case-control study
    Perucca P, Jacoby A, Marson AG, Baker GA, Lane S, Benn EK, Thurman DJ, Hauser WA, Gilliam FG, Hesdorffer DC.
    Neurology. 2011 Jan 18;76(3):273-9.

  45. Thrombocytopenia after vaccination: case reports to the US Vaccine Adverse Event Reporting System, 1990-2008
    Woo EJ, Wise RP, Menschik D, Shadomy SV, Iskander J, Beeler J, Varricchio F, Ball R.
    Vaccine. 2011 Feb 1;29(6):1319-23.

  46. Age and gender trends in long-term opioid analgesic use for noncancer pain
    Campbell CI, Weisner C, Leresche L, Ray GT, Saunders K, Sullivan MD, Banta-Green CJ, et al.
    Am J Public Health. 2010 Dec;100(12):2541-7.

  47. Opioid prescriptions for chronic pain and overdose: a cohort study
    Dunn KM, Saunders KW, Rutter CM, Banta-Green CJ, Merrill JO, Sullivan MD, Weisner CM, et al.
    Ann Intern Med. 2010 Jan 19;152(2):85-92.

  48. Trends in opioid use and dosing among socio-economically disadvantaged patients
    Gomes T, Juurlink D, Dhalla I, Mailis-Gagnon A, Paterson J, Mamdani M.
    Open Med. 2011 Feb;5(1).

  49. Clinical characteristics of veterans prescribed high doses of opioid medications for chronic non-cancer pain
    Morasco BJ, Duckart JP, Carr TP, Deyo RA, Dobscha SK.
    Pain. 2010 Dec;151(3):625-32.

  50. A flood of opioids, a rising tide of deaths
    Okie S.
    N Engl J Med. 2010 Nov 18;363(21):1981-5.

  51. Increasing deaths involving oxycodone, Victoria, Australia, 2000-09
    Rintoul AC, Dobbin MD, Drummer OH, Ozanne-Smith J.
    Inj Prev. 2010 Jan 7.

  52. A population-based cohort study on chronic pain: the role of opioids
    Sjogren P, Gronbaek M, Peuckmann V, Ekholm O.
    Clin J Pain. 2010 Nov-Dec;26(9):763-9.

  53. Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: the TROUP study
    Sullivan MD, Edlund MJ, Fan MY, Devries A, Brennan Braden J, Martin BC.
    Pain. 2010 Aug;150(2):332-9.

  54. Maternal treatment with opioid analgesics and risk for birth defects
    Broussard CS, Rasmussen SA, Reefhuis J, Friedman JM, Jann MW, Riehle-Colarusso T, Honein MA.
    Am J Obstet Gynecol. 2011 Feb 21.

  55. Prescription drug monitoring programs and death rates from drug overdose
    Paulozzi LJ, Kilbourne EM, Desai HA.
    Pain Med. 2011 Feb 18.

  56. Time to change the paradigm--from "potentially inappropriate" to real patient harms
    Shehab N, Budnitz DS.
    Arch Intern Med. 2011 Mar 14;171(5):473-4.

  57. Paraplegia and paraparesis from intrathecal methotrexate and cytarabine contaminated with trace amounts of vincristine in China during 2007
    Zeng G, Ma H, Wang X, Yan H, Wan X, Jiang B, Fontaine RE, Wu Z, Lin S, Ruan F, Liu H.
    J Clin Oncol. 2011 Mar 21.

  58. Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device
    Sessink PJ, Connor TH, Jorgenson JA, Tyler TG.
    J Oncol Pharm Pract. 2011 Mar;17(1):39-48.

  59. Exposure to hazardous drugs in healthcare: an issue that will not go away
    Davis J, McLauchlan R, Connor TH.
    J Oncol Pharm Pract. 2011 Mar;17(1):9-13.

  60. Levothyroxine dose and risk of fractures in older adults: nested case-control study
    Turner M, Camacho X, Fischer H, Austin P, Anderson G, Rochon P, Liscombe L.
    BMJ. 2011 ;342(d2238).

  61. Putting risk into perspective: the US medical eligibility criteria for contraceptive use
    Curtis KM, Tepper NK, Marchbanks PA.
    Rev Endocr Metab Disord. 2011 May 5.

  62. Antimicrobial and antimotility agent use in persons with Shiga toxin-producing Escherichia coli O157 infection in FoodNet sites
    Nelson JM, Griffin PM, Jones TF, Smith KE, Scallan E.
    Clin Infect Dis. 2011 May;52(9):1130-2.

  63. A national epidemic of unintentional prescription opioid overdose deaths: how physicians can help control it
    Paulozzi LJ, Weisler RH, Patkar AA.
    J Clin Psychiatry. 2011 Apr 19.

  64. Emergency department visits for overdoses of acetaminophen-containing products
    Budnitz DS, Lovegrove MC, Crosby AE.
    Am J Prev Med. 2011 Jun;40(6):585-92.

  65. Preventing medication overdoses in young children: an opportunity for harm elimination
    Budnitz DS, Salis S.
    Pediatrics. 2011 May 9.

  66. Emergency department visits for antiviral adverse events during the 2009 H1N1 influenza pandemic
    Lovegrove MC, Shehab N, Hales CM, Poneleit K, Crane E, Budnitz DS.
    Public Health Rep. 2011 May-Jun;126(3):312-7.

  67. Characterization of acetaminophen overdose-related emergency department visits and hospitalizations in the United States
    Manthripragada AD, Zhou EH, Budnitz DS, Lovegrove MC, Willy ME.
    Pharmacoepidemiol Drug Saf. 2011 Aug;20(8):819-26.

  68. Antimicrobial ointments and methicilllin-resistant Staphylococcus aureus USA 300
    Suzuki M, Yamada K, Nagao M, Aoki E, Matsumoto M, Hirayama T, Yamamoto H, Hiramatsu R, Ichiyama S.
    Emerg Infect Dis. 2011 Oct.

  69. The last mile: taking the final steps in preventing pediatric pharmaceutical poisonings
    Budnitz DS, Lovegrove MC.
    J Pediatr. 2011 Nov 5.

  70. Oral contraceptive formulation and risk of breast cancer
    Marchbanks PA, Curtis KM, Mandel MG, Wilson HG, Jeng G, Folger SG, McDonald JA, Daling JR, Bernstein L, Malone KE, Wingo PA, Simon MS, Norman SA, Strom BL, Ursin G, Weiss LK, Burkman RT, Spirtas R.
    Contraception. 2011 Sep 28.

  71. Emergency hospitalizations for adverse drug events in older Americans
    Budnitz DS, Lovegrove MC, Shehab N, Richards CL.
    N Engl J Med. 2011 Nov 24;365(21):2002-12.

  72. Monitoring for tuberculosis drug hepatotoxicity: moving from opinion to evidence
    Saukkonen JJ, Powell K, Jereb JA.
    Am J Respir Crit Care Med. 2012 Mar 15;185(6):598-9.

  73. Peramivir use for treatment of hospitalized patients with influenza A(H1N1)pdm09 under Emergency Use Authorization, October 2009 - June 2010
    Yu Y, Garg S, Yu PA, Kim HJ, Patel A, Merlin T, Redd S, Uyeki TM.
    Clin Infect Dis. 2012 Apr 5.

  74. Nevirapine-associated hepatotoxicity and rash among HIV-infected pregnant women in Kenya
    Peters PJ, Polle N, Zeh C, Masaba R, Borkowf CB, Oyaro B, Omolo P, Ogindo P, Ndivo R, Angira F, Lando R, Fowler MG, Weidle PJ, Thomas TK.
    J Int Assoc Physicians AIDS Care (Chic). 2012 Mar-Apr;11(2):142-9.

  75. Safety and pharmacokinetics of escalating daily doses of the antituberculosis drug rifapentine in healthy volunteers
    Dooley KE, Bliven-Sizemore EE, Weiner M, Lu Y, Nuermberger EL, Hubbard WC, Fuchs EJ, Melia MT, Burman WJ, Dorman SE.
    Clin Pharmacol Ther. 2012 Apr 4.

  76. Does maternal use of tenofovir during pregnancy affect growth of HIV-exposed uninfected infants?
    Kuhn L, Bulterys M.
    AIDS. 2012 Jun 1;26(9):1167-9.

  77. Methadone-related emergency department visits involving nonmedical use.
    Substance Abuse and Mental Health Services Administration (SAMHSA).
    The DAWN Report. 2012 2012.

  78. A modeling and simulation approach to characterize methadone QT prolongation using pooled data from five clinical trials in MMT patients
    Florian J, Garnett CE, Nallani SC, Rappaport BA, Throckmorton DC.
    Clin Pharmacol Ther. 2012 Apr;91(4):666-72.

  79. Methadone: a review of drug-drug and pathophysiological interactions
    Kapur BM, Hutson JR, Chibber T, Luk A, Selby P.
    Crit Rev Clin Lab Sci. 2011 Jul-Aug;48(4):171-95.

  80. The methadone epidemic: methadone-related deaths on the rise in Vermont
    Madden ME, Shapiro SL.
    Am J Forensic Med Pathol. 2011 Jun;32(2):131-5.

  81. *Indicators of buprenorphine and methadone use and abuse: what do we know?
    Maxwell JC, McCance-Katz EF.
    Am J Addict. 2010 Jan-Feb;19(1):73-88.

  82. *Oral methadone for chronic noncancer pain: a systematic literature review of reasons for administration, prescription patterns, effectiveness, and side effects
    Sandoval JA, Furlan AD, Mailis-Gagnon A.
    Clin J Pain. 2005 Nov-Dec;21(6):503-12.

  83. An analysis of the root causes for opioid-related overdose deaths in the United States
    Webster LR, Cochella S, Dasgupta N, Fakata KL, Fine PG, Fishman SM, Grey T, et al.
    Pain Med. 2011 Jun;12 Suppl 2:S26-35.

  84. The source of methadone in overdose deaths in Western Virginia in 2004
    Weimer MB, Korthuis PT, Behonick GS, Wunsch MJ.
    J Addict Med. 2011 Sep;5(3):188-202.

  85. Inappropriate medication in home health care
    Lau DT, Dwyer LL.
    J Gen Intern Med. 2012 May;27(5):490; author reply 491.

  86. The association of statin use with peripheral neuropathy in the US population 40 years of age or older
    Tierney EF, Thurman DJ, Beckles GL, Cadwell BL.
    J Diabetes. 2012 Nov 1.

  87. Use of topiramate in pregnancy and risk of oral clefts
    Margulis AV, Mitchell AA, Gilboa SM, Werler MM, Mittleman MA, Glynn RJ, Hernandez-Diaz S.
    Am J Obstet Gynecol. 2012 Nov;207(5):405 e1-7.

  88. Clarification about hazardous drugs
    Connor TH, Mackenzie BA, Debord DG.
    Am J Health Syst Pharm. 2012 Nov 15;69(22):1949-50.

  89. Fungal infections associated with contaminated methylprednisolone injections - preliminary report
    Smith RM, Schaefer MK, Kainer MA, Wise M, Finks J, Duwve J, Fontaine E, Chu A, Carothers B, Reilly A, Fiedler J, Wiese AD, Feaster C, Gibson L, Griese S, Purfield A, Cleveland AA, Benedict K, Harris JR, Brandt ME, Blau D, Jernigan J, Weber JT, Park BJ.
    N Engl J Med. 2012 Dec 19.

  90. If not now, when? Seizing the moment for antibiotic stewardship
    Pollack LA, Gould CV, Srinivasan A.
    Infect Control Hosp Epidemiol. 2013 Feb;34(2):117-8.

  91. Safe lists for medications in pregnancy: inadequate evidence base and inconsistent guidance from Web-based information, 2011
    Peters SL, Lind JN, Humphrey JR, Friedman JM, Honein MA, Tassinari MS, Moore CA, Mathis LL, Broussard CS.
    Pharmacoepidemiol Drug Saf. 2013 Jan 29.

  92. Clinical experience with intravenous zanamivir under an emergency investigational new drug program in the United States
    Chan-Tack KM, Gao A, Himaya AC, Thompson EG, Singer ME, Uyeki TM, Birnkrant DB.
    J Infect Dis. 2013 Jan 1;207(1):196-8.

  93. Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate (TDF) among HIV-uninfected men who have sex with men (MSM) in the United States
    Grohskopf LA, Chillag KL, Gvetadze R, Liu AY, Thompson M, Mayer KH, Collins BM, Pathak SR, O'Hara B, Ackers ML, Rose CE, Grant RM, Paxton LA, Buchbinder SP.
    J Acquir Immune Defic Syndr. 2013 Mar 5.

  94. Medications as a potential source of exposure to phthalates among women of childbearing age
    Hernandez-Diaz S, Su YC, Mitchell AA, Kelley KE, Calafat AM, Hauser R.
    Reprod Toxicol. 2013 Jan 18;37C:1-5.

  95. Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 2007-2010
    Greene SK, Li L, Shay DK, Fry AM, Lee GM, Jacobsen SJ, Baxter R, Irving SA, Jackson ML, Naleway AL, Nordin JD, Narwaney KJ, Lieu TA.
    Pharmacoepidemiol Drug Saf. 2013 Apr;22(4):335-44.

  96. Opioid prescribing in emergency departments: the prevalence of potentially inappropriate prescribing and misuse
    Logan J, Liu Y, Paulozzi L, Zhang K, Jones C.
    Med Care. 2013 Apr 29.

  97. Efficacy of flow restrictors in limiting access of liquid medications by young children
    Lovegrove MC, Hon S, Geller RJ, Rose KO, Hampton LM, Bradley J, Budnitz DS.
    J Pediatr. 2013 Jul 26.

  98. Profiling cholinesterase adduction: a high-throughput prioritization method for organophosphate exposure samples
    Carter MD, Crow BS, Pantazides BG, Watson CM, Decastro BR, Thomas JD, Blake TA, Johnson RC.
    J Biomol Screen. 2013 Aug 16.

  99. Inhibition of glutathione biosynthesis alters compartmental redox status and the thiol proteome in organogenesis-stage rat conceptuses
    Harris C, Shuster DZ, Roman Gomez R, Sant KE, Reed MS, Pohl J, Hansen JM.
    Free Radic Biol Med. 2013 Oct;63:325-37.

  100. Inhibition of glutathione biosynthesis alters compartmental redox status and the thiol proteome in organogenesis-stage rat conceptuses
    Harris C, Shuster DZ, Roman Gomez R, Sant KE, Reed MS, Pohl J, Hansen JM.
    Free Radic Biol Med. 2013 Oct;63:325-37.

  101. US-based emergency department visits for fluoroquinolone-associated hypersensitivity reactions
    Jones SC, Budnitz DS, Sorbello A, Mehta H.
    Pharmacoepidemiol Drug Saf. 2013 Oct;22(10):1099-106.

  102. Prophylaxis and treatment of anthrax in pregnant women
    Meaney-Delman D, Rasmussen SA, Beigi RH, Zotti ME, Hutchings Y, Bower WA, Treadwell TA, Jamieson DJ.
    Obstet Gynecol. 2013 Oct;122(4):885-900.

  103. US-based emergency department visits for fluoroquinolone-associated hypersensitivity reactions
    Jones SC, Budnitz DS, Sorbello A, Mehta H.
    Pharmacoepidemiol Drug Saf. 2013 Oct;22(10):1099-106.

  104. Prophylaxis and treatment of anthrax in pregnant women
    Meaney-Delman D, Rasmussen SA, Beigi RH, Zotti ME, Hutchings Y, Bower WA, Treadwell TA, Jamieson DJ.
    Obstet Gynecol. 2013 Oct;122(4):885-900.

  105. Interventions to improve antibiotic prescribing practices in ambulatory care
    Arnold SR, Straus SE.
    Cochrane Database Syst Rev. 2005 (4):CD003539.

  106. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship
    Dellit TH, Owens RC, McGowan JE, Gerding DN, Weinstein RA, Burke JP, Huskins WC, et al.
    Clin Infect Dis. 2007 Jan 15;44(2):159-77.

  107. Antimicrobial stewardship
    Fishman N.
    Am J Infect Control. 2006 Jun;34(5 Suppl 1):S55-63; discussion S64-73.

  108. Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS)
    Fishman N.
    Infect Control Hosp Epidemiol. 2012 Apr;33(4):322-7.

  109. Implementing a strategy for monitoring inpatient antimicrobial use among hospitals in the United States
    Fridkin SK, Srinivasan A.
    Clin Infect Dis. 2013 Oct 25.

  110. Principles of judicious antibiotic prescribing for bacterial upper respiratory tract infections in pediatrics
    Hersh AL, Jackson M, Hicks LA.
    Pediatrics. 2013 Nov 18;132:1146-54.

  111. U.S. outpatient antibiotic prescribing, 2010
    Hicks LA, Taylor TH, Hunkler RJ.
    N Engl J Med. 2013 Apr 11;368(15):1461-2.

  112. Antibiotic resistance threats in the United States
    Centers for Disease Control and Prevention.
    . 2013 .

  113. Antibiotic prescribing for adults in ambulatory care in the USA, 2007-09
    Shapiro DJ, Hicks LA, Pavia AT, Hersh AL.
    J Antimicrob Chemother. 2013 Jul 25.

  114. A national evaluation of antibiotic expenditures by healthcare setting in the United States, 2009
    Suda KJ, Hicks LA, Roberts RM, Hunkler RJ, Danziger LH.
    J Antimicrob Chemother. 2013 Mar;68(3):715-8.

  115. Trends and geographic patterns in drug-poisoning death rates in the U.S., 1999-2009
    Rossen LM, Khan D, Warner M.
    Am J Prev Med. 2013 Dec;45(6):e19-25.

  116. Trends and geographic patterns in drug-poisoning death rates in the U.S., 1999-2009
    Rossen LM, Khan D, Warner M.
    Am J Prev Med. 2013 Dec;45(6):e19-25.

  117. Emergency department visits and hospitalizations for digoxin toxicity: United States, 2005-2010
    See I, Shehab N, Kegler SR, Laskar SR, Budnitz DS.
    Circ Heart Fail. 2013 Dec 3.

  118. Vaccines and pregnancy: past, present, and future
    Rasmussen SA, Watson AK, Kennedy ED, Broder KR, Jamieson DJ.
    Semin Fetal Neonatal Med. 2013 Dec 16.

  119. Streptococcus pneumoniae non-susceptibility and outpatient antimicrobial prescribing rates at the Alaska Native Medical Center
    Stevens RW, Wenger J, Bulkow L, Bruce MG.
    Int J Circumpolar Health. 2013 ;72.

  120. Preparing for safety monitoring after rotavirus vaccine implementation: a retrospective review of intussusception cases among children at a large teaching hospital in Rwanda, 2009-2012
    Ngendahayo E, Bonane A, Ntakiyiruta G, Munyanshongore A, Muganga N, Bikoroti J, Mwenda JM, Tate JE, Ngabo F.
    Pediatr Infect Dis J. 2014 Jan;33 Suppl 1:S99-S103.

  121. Cough and cold medication adverse events after market withdrawal and labeling revision
    Hampton LM, Nguyen DB, Edwards JR, Budnitz DS.
    Pediatrics. 2013 Dec;132(6):1047-54.

  122. Fungal endophthalmitis associated with compounded products
    Mikosz CA, Smith RM, Kim M, Tyson C, Lee EH, Adams E, Straif-Bourgeois S, Sowadsky R, Arroyo S, Grant-Greene Y, Duran J, Vasquez Y, Robinson BF, Harris JR, Lockhart SR, Torok TJ, Mascola L, Park BJ.
    Emerg Infect Dis. 2014 Feb;20(2):248-56.

  123. Adherence to label and device recommendations for over-the-counter pediatric liquid medications
    Budnitz DS, Lovegrove MC, Rose KO.
    Pediatrics. 2014 Feb;133(2):e283-90.

  124. High-risk use by patients prescribed opioids for pain and its role in overdose deaths
    Baumblatt JA, Wiedeman C, Dunn JR, Schaffner W, Paulozzi LJ, Jones TF.
    JAMA Intern Med. 2014 Mar 3.

  125. Bone mineral density changes among HIV-uninfected young adults in a randomised trial of pre-exposure prophylaxis with tenofovir-emtricitabine or placebo in Botswana
    Kasonde M, Niska RW, Rose C, Henderson FL, Segolodi TM, Turner K, Smith DK, Thigpen MC, Paxton LA.
    PLoS One. 2014 ;9(3):e90111.

  126. Emergency department visits and hospitalizations for digoxin toxicity: United States, 2005 to 2010
    See I, Shehab N, Kegler SR, Laskar SR, Budnitz DS.
    Circ Heart Fail. 2014 Jan;7(1):28-34.

  127. Outbreak of Serratia marcescens bloodstream infections in patients receiving parenteral nutrition prepared by a compounding pharmacy
    Gupta N, Hocevar SN, Moulton-Meissner H, Stevens KM, McIntyre MG, Jensen B, Kuhar DT, Noble-Wang J, Schnatz RG, Becker SC, Kastango ES, Shehab N, Kallen AJ.
    Clin Infect Dis. 2014 Apr 11.

  128. Risk of adverse health outcomes with increasing duration and regularity of opioid therapy
    Paulozzi LJ, Zhang K, Jones CM, Mack KA.
    J Am Board Fam Med. 2014 May-Jun;27(3):329-38.

  129. Renal function of participants in the Bangkok Tenofovir Study, Thailand, 2005-2012
    Martin M, Vanichseni S, Suntharasamai P, Sangkum U, Mock PA, Gvetadze RJ, Curlin ME, Leethochawalit M, Chiamwongpaet S, Cherdtrakulkiat T, Anekvorapong R, Leelawiwat W, Chantharojwong N, McNicholl JM, Paxton LA, Kittimunkong S, Choopanya K.
    Clin Infect Dis. 2014 May 14.

  130. *"Safe and effective when used as directed": the case of chronic use of opioid analgesics
    Ballantyne JC.
    J Med Toxicol. 2012 Sep 15;8(4):417-23.

  131. High-risk use by patients prescribed opioids for pain and its role in overdose deaths
    Baumblatt JA, Wiedeman C, Dunn JR, Schaffner W, Paulozzi LJ, Jones TF.
    JAMA Intern Med. 2014 Mar 3;174(5):796-801.

  132. Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States
    Cicero TJ, Surratt H, Inciardi JA, Munoz A.
    Pharmacoepidemiol Drug Saf. 2007 Jul 18;16(8):827-40.

  133. Factors predicting development of opioid use disorders among individuals who receive an initial opioid prescription: mathematical modeling using a database of commercially-insured individuals
    Cochran BN, Flentje A, Heck NC, Van Den Bos J, Perlman D, Torres J, Valuck R, et al.
    Drug Alcohol Depend. 2014 Mar 12;138:202-8.

  134. The Dartmouth atlas of Medicare prescription drug use
    Munson J., Morden N., Goodman D., Valle L., Wennberg J..
    The Dartmouth Atlas Project. 2013 .

  135. Polydrug abuse: a review of opioid and benzodiazepine combination use
    Jones JD, Mogali S, Comer SD.
    Drug Alcohol Depend. 2012 Sep 1;125(1-2):8-18.

  136. Geographic variation in opioid prescribing in the U.S.
    McDonald DC, Carlson K, Izrael D.
    J Pain. 2012 Oct;13(10):988-96.

  137. *Prescription drug overdoses: a review
    Paulozzi LJ.
    J Safety Res. 2012 Sep;43(4):283-9.

  138. Opioid analgesics and rates of fatal drug poisoning in the United States
    Paulozzi LJ, Ryan GW.
    Am J Prev Med. 2006 Dec;31(6):506-11.

  139. Geographic variation in outpatient antibiotic prescribing among older adults
    Zhang Y, Steinman MA, Kaplan CM.
    Arch Intern Med. 2012 Oct 22;172(19):1465-71.

  140. Decline in drug overdose deaths after state policy changes - Florida, 2010-2012
    Johnson H, Paulozzi L, Porucznik C, Mack K, Herter B.
    MMWR Morb Mortal Wkly Rep. 2014 Jul 4;63(26):569-74.

  141. Vital signs: variation among states in prescribing of opioid pain relievers and benzodiazepines - United States, 2012
    Paulozzi LJ, Mack KA, Hockenberry JM.
    MMWR Morb Mortal Wkly Rep. 2014 Jul 4;63(26):563-8.

  142. Decline in drug overdose deaths after state policy changes - Florida, 2010-2012
    Johnson H, Paulozzi L, Porucznik C, Mack K, Herter B.
    MMWR Morb Mortal Wkly Rep. 2014 Jul 4;63(26):569-74.

  143. Vital signs: variation among states in prescribing of opioid pain relievers and benzodiazepines - United States, 2012
    Paulozzi LJ, Mack KA, Hockenberry JM.
    MMWR Morb Mortal Wkly Rep. 2014 Jul 4;63(26):563-8.

 

To subscribe to CDC Science Clips email updates, enter your email address:

Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
    24 Hours/Every Day
  • cdcinfo@cdc.gov
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #